Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2012
05/16/2012CN101632744B Chinese traditional medicine composition for treating repeated cold of infants
05/16/2012CN101306019B Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
05/15/2012US8178713 Sulfur-containing phospholipid derivatives
05/15/2012US8178671 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178574 Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide
05/15/2012US8178093 Method for treating infectious disease using monoclonal antibodies
05/15/2012CA2681922C Zinc finger protein derivatives and methods therefor
05/15/2012CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
05/15/2012CA2478553C Probiotic delivery system
05/15/2012CA2461730C Novel cyclosporin analog microemulsion preconcentrates
05/15/2012CA2450476C A soluble complex comprising a retroviral surface glycoprotein
05/15/2012CA2439452C High-affinity antagonists of elr-cxc chemokines
05/15/2012CA2430978C Vla-4 inhibitors
05/15/2012CA2409286C Dog & cat food compositions having a probiotic lactobacillus strain
05/15/2012CA2398229C Improved dna vaccines for production-type animals
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/10/2012WO2012061696A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors
05/10/2012WO2012061459A1 Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases
05/10/2012WO2012061415A1 Oxypyrimidines as syk modulators
05/10/2012WO2012061203A1 Enhancement of pathogen-specific memory th17 cell responses
05/10/2012WO2012061169A1 Benzimidazole inhibitors of leukotriene production
05/10/2012WO2012061129A1 Treatment of gastrointestinal inflammation and psoriasis a
05/10/2012WO2012060783A1 THE USE OF β-D-GLUCAN TO REDUCE THE ADVERSE EFFECT OF THE IMMUNE RESPONSE DEPRESSION INDUCED BY EXCESSIVE PHYSICAL EXERCISE
05/10/2012WO2012059932A1 2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
05/10/2012WO2012059820A1 Temperature sensitive hydrogel and block copolymers
05/10/2012WO2012059571A1 USE OF ATOMIC QUANTUM CLUSTERS (AQCs) IN THE PREVENTION OF AUTOIMMUNE DISEASES
05/10/2012WO2012059513A1 Mmp8 inactivating antigen binding proteins
05/10/2012WO2012058935A1 Total polysaccharides of radix isatidis and their fractions, and uses thereof as vaccine adjuvants
05/10/2012WO2012058768A1 Stable heterodimeric antibody design with mutations in the fc domain
05/10/2012WO2012026309A9 Creation of anti-pad4 antibody pharmaceutical
05/10/2012WO2012024427A3 Human facilitating cells and uses thereof
05/10/2012WO2012021578A8 Use of angiotensin- ii (1-7) in cell transplantation and as an agent for preventing/treating norovirus infection
05/10/2012WO2012020021A9 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
05/10/2012US20120115940 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
05/10/2012US20120115932 Modulation of stat 6 expression
05/10/2012US20120115921 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
05/10/2012US20120115916 Oxazole and thiazole derivatives as alx receptor agonists
05/10/2012US20120115906 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115895 Tricyclic indole-derived spiro derivatives as crth2 modulators
05/10/2012US20120115890 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/10/2012US20120115889 Inhibitors of bruton's tyrosine kinase
05/10/2012US20120115886 Fused pyrimidineone compounds as trpv3 modulators
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115864 Substituted Fused Pyrimidine Compounds
05/10/2012US20120115862 Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compounds
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115840 Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acid
05/10/2012US20120115832 TGR5 Modulators and Methods of Use Thereof
05/10/2012US20120115825 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/10/2012US20120115803 Treatment of acinetobacter with alginate oligomers and antibiotics
05/10/2012US20120115798 Method for improving the immunity of a companion animal
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom
05/10/2012US20120114746 Immunostimulatory Compositions Comprising Liposome-Encapsulated Oligonucleotides and Epitopes
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114701 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
05/10/2012US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use
05/10/2012US20120114699 Allergoids Derived from Allergens
05/10/2012US20120114698 Salmonella marker vaccine
05/10/2012US20120114694 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
05/10/2012US20120114693 Nucleic acid mucosal immunization
05/10/2012US20120114692 Immunogenic compositions containing phospholipid
05/10/2012US20120114691 Vaccine against african horse sickness virus
05/10/2012US20120114688 Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis
05/10/2012US20120114687 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
05/10/2012US20120114686 Compositions and methods related to protein a (spa) variants
05/10/2012US20120114685 Compositions comprising angiogenic factors and methods of use thereof
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114683 Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
05/10/2012US20120114681 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
05/10/2012US20120114680 Dendritic Cell Compositions and Methods
05/10/2012US20120114678 Treatment for nephritis
05/10/2012US20120114677 Modified nicotinic compounds and related methods
05/10/2012US20120114675 Foxp3+ natural killer t-cells and the treatment of immune related diseases
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114663 Methods to treat allergic conditions
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a)
05/10/2012US20120114651 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
05/10/2012US20120114649 Compositions of pd-1 antagonists and methods of use
05/10/2012US20120114646 Lyophilized formulations for small modular immunopharmaceuticals
05/10/2012US20120114635 Antibodies to cross-linked amyloid beta oligomers
05/10/2012US20120114633 Inhibitors Of Bacterial Type III Secretion System
05/10/2012US20120114608 Compositions, methods and kits for enhancing immune response to a respiratory condition
05/10/2012US20120114604 Combinations for HCV Treatment
05/10/2012US20120114599 Opioid and opioid-like compounds and uses thereof
05/10/2012US20120114597 Cd4+cd25- t cells and tr1-like regulatory t cells
05/10/2012US20120114595 Sugar chain-added ailim extracellular domain and method for producing same
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 1172